MedTrace Logo

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

NCT01313533 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 540

Last updated 2019-04-04

No results posted yet for this study

Summary

The purpose of this study is to study the effects of polyarginine treated vein grafts on graft patency for patients undergoing coronary artery bypass surgery.

Conditions

Interventions

DRUG

Polyarginine

Vein soak treated with polyarginine

DRUG

Vein soak treated with Lactated Ringers Solution

Vein soak

Sponsors & Collaborators

  • St. Luke's Hospital, Chesterfield, Missouri

    lead OTHER

Principal Investigators

  • Ronald D Leidenfrost, MD · St. Luke's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2019-12-31
Completion
2021-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01313533 on ClinicalTrials.gov